
S.A.G. Pharma Private Limited
About S.A.G. Pharma Private Limited
Data last updated:
S.A.G. Pharma Private Limited is a private limited company based in Ambala, Haryana, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 02 February 2022.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U24290HR2022PTC101044.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Ajay Gupta and Sanjay Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 512 B – 6 Behind Police Post No. 2 Railway Road, Ambala, Haryana, India – 134003.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.07 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net loss of ₹34,200 (net margin -0.3%) and EBITDA of ₹2.06 Lakh (EBITDA margin 1.9%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address512 B – 6 Behind Police Post No. 2 Railway Road, Ambala, Haryana, India – 134003
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of S.A.G. Pharma Private Limited
The main business activity of S.A.G. Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of S.A.G. Pharma Private Limited FY 2025 filings available
S.A.G. Pharma Private Limited reported revenue of ₹1.07 Cr (up 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of S.A.G. Pharma Private Limited
Revenue rose 3% in the latest year. EBITDA rose 14% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of S.A.G. Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | ₹2.06 Lakh | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹34,200 | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of S.A.G. Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 1.9% | •••• | •••• | •••• |
| Net Profit Margin | -0.3% | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of S.A.G. Pharma are in the company report.
Financial statements from FY 2022
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of S.A.G. Pharma Private Limited
S.A.G. Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Gurumeher Impex Private Limited | ₹1.07 Cr (FY 2025) | •••• | •••• | -12.0% | •••• | Hyderabad, Telangana, India |
| Health Essentials (India) Private Limited | ₹1.07 Cr (FY 2020) | •••• | •••• | -44.0% | •••• | Hyderabad, Telangana, India |
| Bibek Commerce & Infra Private Limited | ₹1.07 Cr (FY 2019) | •••• | •••• | -95.0% | •••• | New Delhi, Delhi, India |
| Sundawn Industries Private Limited | ₹1.07 Cr (FY 2025) | •••• | •••• | -76.0% | •••• | Noida, Uttar Pradesh, India |
| Ushas Aquafoods Private Limited | ₹1.07 Cr (FY 2023) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| S.A.G. Pharma Private Limited this company | ₹1.07 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | Ambala, Haryana, India |
| Neolife Pharmaceuticals Private Limited | ₹1.07 Cr (FY 2023) | •••• | •••• | 57.0% | •••• | Nagole, Hyderabad, Telangana, India |
| Zam Zam Creations Private Limited | ₹1.07 Cr (FY 2025) | •••• | •••• | -54.0% | •••• | New Delhi, Delhi, India |
| Wimpex Exports Private Limited | ₹1.07 Cr (FY 2025) | •••• | •••• | 13.0% | •••• | New Delhi, Delhi, India |
| Organica Pure Farm Products Private Limited | ₹1.07 Cr (FY 2024) | •••• | •••• | -6.0% | •••• | Delhi, India |
| K.A. Petrochem Private Limited | ₹1.07 Cr (FY 2024) | •••• | •••• | •••• | Kolkata, West Bengal, India |
Peers are the five companies nearest above and the five nearest below S.A.G. Pharma by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of S.A.G. Pharma Private Limited
S.A.G. Pharma has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ajay Gupta | Director | 02 Feb 2022 | 4 Years 8 Months | Current |
| Sanjay Gupta Also directs: Cardean Lifesciences Private Limited | Director | 02 Feb 2022 | 4 Years 8 Months | Current |
| Aman Gupta Also directs: Cardean Lifesciences Private Limited | Director | 16 Jun 2022 | 4 Years 3 Months | Current |
| Raghav Gupta Also directs: Cardean Lifesciences Private Limited | Director | 16 Jun 2022 | 4 Years 3 Months | Current |
Charges & Borrowings of S.A.G. Pharma Private Limited
S.A.G. Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at S.A.G. Pharma Private Limited
Employment history and EPFO contributions of people linked to S.A.G. Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on S.A.G. Pharma Private Limited
S.A.G. Pharma Private Limited has 4 board changes on record since 2022: 4 appointments. The latest: Aman Gupta was appointed as Director on 16 Jun 2022.
Credit Ratings, Litigation & Regulatory Alerts for S.A.G. Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by S.A.G. Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of S.A.G. Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of S.A.G. Pharma Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of S.A.G. Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about S.A.G. Pharma Private Limited
S.A.G. Pharma is an active private limited company based in Ambala, Haryana, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 02 February 2022 (4+ years old) and is registered under CIN U24290HR2022PTC101044.
S.A.G. Pharma reported revenue of ₹1.07 Cr for FY 2025 (up 3% YoY).
S.A.G. Pharma has 4 current directors:
- Ajay Gupta - Director
- Sanjay Gupta - Director
- Aman Gupta - Director
- Raghav Gupta - Director
S.A.G. Pharma reported a net loss of ₹34,200 (net margin -0.3%) and EBITDA of ₹2.06 Lakh (EBITDA margin 1.9%) for FY 2025, as per its filed financial statements.
The CIN (Corporate Identification Number) of S.A.G. Pharma is U24290HR2022PTC101044. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
S.A.G. Pharma was incorporated on 02 February 2022, making it 4+ years old. It is registered with the Registrar of Companies, Haryana.
The peers of S.A.G. Pharma by revenue are Gurumeher Impex Private Limited, Health Essentials (India) Private Limited, Bibek Commerce & Infra Private Limited, Sundawn Industries Private Limited, Ushas Aquafoods Private Limited and 5 more, all in the same principal business activity (Wholesale Trading).
Aman Gupta was appointed as Director on 16 Jun 2022. Raghav Gupta was appointed as Director on 16 Jun 2022. Ajay Gupta was appointed as Director on 02 Feb 2022. S.A.G. Pharma has 4 board changes on record in total.
The registered office of S.A.G. Pharma is at 512 B – 6 Behind Police Post No. 2 Railway Road, Ambala, Haryana, India – 134003.
S.A.G. Pharma has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh.
S.A.G. Pharma operates in the chemicals industry, in the manufacturing segment.